<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996043</url>
  </required_header>
  <id_info>
    <org_study_id>21-042-B2</org_study_id>
    <nct_id>NCT04996043</nct_id>
  </id_info>
  <brief_title>Efficacy Testing of Collagen Peptide Drink</brief_title>
  <official_title>Efficacy Testing of Collagen Peptide Drink</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TCI Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TCI Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess Collagen Peptide Drink on skin condition improvement&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 18, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of skin wrinkles</measure>
    <time_frame>Change from Baseline skin wrinkles at 4 weeks</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin texture</measure>
    <time_frame>Change from Baseline skin texture at 4 weeks</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin collagen density</measure>
    <time_frame>Change from Baseline skin collagen density at 4 weeks</time_frame>
    <description>DermaLab® Series SkinLab Combo was utilized to measure skin pores. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin elasticity</measure>
    <time_frame>Change from Baseline skin elasticity at 4 weeks</time_frame>
    <description>Soft Plus was utilized to measure skin elasticity. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of MMP-1 of blood</measure>
    <time_frame>Change from Baseline MMP-1 at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure MMP-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of TIMP-1 of blood</measure>
    <time_frame>Change from Baseline TIMP-1 at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure TIMP-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of skin melanin index</measure>
    <time_frame>Change from Baseline skin melanin index at 4 weeks</time_frame>
    <description>Soft Plus was utilized to measure skin melanin index. Units: arbitrary units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of skin L* value</measure>
    <time_frame>Change from Baseline L* value at 4 weeks</time_frame>
    <description>Chroma Meter MM500 was utilized to measure skin L* value. Units: arbitrary units, 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of skin spots</measure>
    <time_frame>Change from Baseline skin spots at 4 weeks</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of skin UV spots</measure>
    <time_frame>Change from Baseline skin UV spots at 4 weeks</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin UV spots. Units: arbitrary units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of skin brown spots</measure>
    <time_frame>Change from Baseline skin brown spots at 4 weeks</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin brown spots. Units: arbitrary units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of TNF-α of blood</measure>
    <time_frame>Change from Baseline TNF-α at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure TNF-α</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of IL-10 of blood</measure>
    <time_frame>Change from Baseline IL-10 at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure IL-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of SOD-RBC of blood</measure>
    <time_frame>Change from Baseline SOD-RBC at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure SOD-RBC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of f-thiols of blood</measure>
    <time_frame>Change from Baseline f-thiols at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure f-thiols</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of t-GSH of blood</measure>
    <time_frame>Change from Baseline t-GSH at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure t-GSH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of GST-RBC of blood</measure>
    <time_frame>Change from Baseline GST-RBC at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure GST-RBC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of MDA of blood</measure>
    <time_frame>Change from Baseline MDA at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure MDA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of skin moisture</measure>
    <time_frame>Change from Baseline skin moisture at 4 weeks</time_frame>
    <description>Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of blood total antioxidant capacity (TAC)</measure>
    <time_frame>Change from Baseline TAC at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of TAC</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The change of total cholesterol of blood</measure>
    <time_frame>Change from Baseline total cholesterol at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure total cholesterol</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of triglyceride of blood</measure>
    <time_frame>Change from Baseline triglyceride at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure triglyceride</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of SGOT of blood</measure>
    <time_frame>Change from Baseline SGOT at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure SGOT</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of SGPT of blood</measure>
    <time_frame>Change from Baseline SGPT at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure SGPT</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of BUN of blood</measure>
    <time_frame>Change from Baseline BUN at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure BUN</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of creatinine of blood</measure>
    <time_frame>Change from Baseline creatinine at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure creatinine</description>
  </other_outcome>
  <other_outcome>
    <measure>The change of uric acid of blood</measure>
    <time_frame>Change from Baseline uric acid at 4 weeks</time_frame>
    <description>Venous blood was sampled to measure uric acid</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Skin Condition</condition>
  <arm_group>
    <arm_group_label>Placebo drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen Peptide Drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Collagen Peptide Drink</intervention_name>
    <description>Testing product</description>
    <arm_group_label>Collagen Peptide Drink</arm_group_label>
    <other_name>Pearlosophy-Collagen Peptide Drink</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <description>Blank</description>
    <arm_group_label>Placebo drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults aged above 20 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject who is not willing to participate in this study.&#xD;
&#xD;
          -  Patients with diseases of the skin, liver, kidney.&#xD;
&#xD;
          -  Subjects who have known cosmetic, drug or food allergies, difficulty in digestive&#xD;
             tract absorption or disorder.&#xD;
&#xD;
          -  Female who is pregnant or nursing or planning to become pregnant during the course of&#xD;
             the study.&#xD;
&#xD;
          -  Received facial laser therapy, chemical peeling or UV overexposure in the past 4&#xD;
             weeks.&#xD;
&#xD;
          -  Constant drug use&#xD;
&#xD;
          -  Participated cosmetic product human study in the past 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chia-Hua Liang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chia Nan University of Pharmacy &amp; Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chia Nan University of Pharmacy ＆ Science</name>
      <address>
        <city>Tainan</city>
        <zip>71710</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

